Sodium-glucose cotransporter 2 inhibitors: a practical guide for the Dutch cardiologist based on real-world experience

Sodium-glucose cotransporter 2 (SGLT2) inhibitors include a relatively new class of glucose-lowering drugs that reduce plasma glucose concentrations by inhibiting proximal tubular reabsorption of glucose in the kidney, while increasing its excretion in urine. Recent large randomised controlled trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwart, K., Velthuis, S., Polyukhovych, Y. V., Mosterd, A., Smidt, L., Serné, E. H., van Raalte, D. H., Elders, P. J. M., Handoko, M. L., Oldenburg-Ligtenberg, P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455761/
https://www.ncbi.nlm.nih.gov/pubmed/34132981
http://dx.doi.org/10.1007/s12471-021-01580-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455761/
https://www.ncbi.nlm.nih.gov/pubmed/34132981
http://dx.doi.org/10.1007/s12471-021-01580-9

Ejemplares similares